Literature DB >> 16233776

Improvements in the cell-free production of functional antibodies using cell extract from protease-deficient Escherichia coli mutant.

Muhamad Ali1, Hirotatsu Suzuki, Takako Fukuba, Xiuping Jiang, Hideo Nakano, Tsuneo Yamane.   

Abstract

Expression of a functional antibody fragment (Fab) using an Escherichia coli cell-free expression system has been reported previously [Jiang et al., FEBS Lett., 514, 290-294 (2002)]. The low yield of the synthesized antibody, however, limits the usefulness of the cell-free expression system, partly due to the degradation of product by endogenous proteases from the E. coli extract. To determine which proteases are responsible for the degradation, we compared the expression of a 6D9 Fab fragment under conditions whereby several protease inhibitors were added into the cell-free system. The addition of serine protease inhibitor increased the amount of the Fab fragment, indicating that serine proteases caused the antibody degradation. Therefore, several serine protease-deficient mutants of E. coli BW25113 were constructed by targeted homologous recombination. The use of extract from a double protease-deficient mutant (DeltadegP-ompT) significantly increased the amount and antigen-binding activities of an anti-HSA scFv and a 6D9 Fab fragment. These results suggest that the DegP- and OmpT-deleted mutant is a useful source of S30 extract for the production or screening of antibodies using the cell-free expression system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16233776     DOI: 10.1263/jbb.99.181

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  5 in total

1.  Combining in Vitro Folding with Cell Free Protein Synthesis for Membrane Protein Expression.

Authors:  Paul J Focke; Christopher Hein; Beate Hoffmann; Kimberly Matulef; Frank Bernhard; Volker Dötsch; Francis I Valiyaveetil
Journal:  Biochemistry       Date:  2016-07-21       Impact factor: 3.162

2.  Constructive approach for synthesis of a functional IgG using a reconstituted cell-free protein synthesis system.

Authors:  Satoshi Murakami; Rena Matsumoto; Takashi Kanamori
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  Evaluating and mitigating clinical samples matrix effects on TX-TL cell-free performance.

Authors:  Peter L Voyvodic; Ismael Conejero; Khouloud Mesmoudi; Eric Renard; Philippe Courtet; Diego I Cattoni; Jerome Bonnet
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

Review 4.  Catalytic Antibodies: Design, Expression, and Their Applications in Medicine.

Authors:  Daqun Zhao; Jie Chen; Xiaoyue Hu; Shujun Zhang
Journal:  Appl Biochem Biotechnol       Date:  2022-10-12       Impact factor: 3.094

5.  A continuous-exchange cell-free protein synthesis system based on extracts from cultured insect cells.

Authors:  Marlitt Stech; Robert B Quast; Rita Sachse; Corina Schulze; Doreen A Wüstenhagen; Stefan Kubick
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.